Erlotinib is a EGFR inhibitor, mainly used for NSCLC and pancreatic cancer with EGFR mutations. It stops the EGFR signaling process. You can get this drug in three strengths: 25, 100, and 150 mg, all in the form of film-coated tablets.
The advice is to take 150 mg once a day, on an empty stomach. Each bottle comes with 30 tablets.
